checkAd

     165  0 Kommentare Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering - Seite 4

    Investor Contact
    Jessica Morris
    Tonix Pharmaceuticals
    investor.relations@tonixpharma.com
    (862) 904-8182

    Peter Vozzo
    ICR Westwicke
    peter.vozzo@westwicke.com
    (443) 213-0505

    Lesen Sie auch

    Media Contact
    Ben Shannon
    ICR Westwicke
    ben.shannon@westwicke.com
    (919) 360-3039



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4
    Verfasst von globenewswire
    Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering - Seite 4 CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase agreement with existing …